Brief: Akebia Therapeutics Announces Appointment Of Nicholas Grund As Chief Commercial Officer
09/01/2024 14:49
Jan 9 (Reuters) - Akebia Therapeutics Inc AKBA.O :
* AKEBIA THERAPEUTICS ANNOUNCES APPOINTMENT OF NICHOLAS
GRUND AS
CHIEF COMMERCIAL OFFICER
Source text for Eikon: ID:nPnjS8rwa
Further company coverage: AKBA.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Akebia Therapeutics
See all newsAkebia Q1 revenue falls, net income misses analyst estimates on higher expenses
Brief: Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Akebia Therapeutics Appoints Biopharmaceutical Leader Philip Vickers To Its Board Of Directors
Akebia posts wider-than-expected Q4 net loss as higher expenses hurt
Brief: Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule